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Background: Follicular lymphomas of the ocular adnexa are very rare in Japan, with only 
two reported cases.
Case: A 44-year-old woman visited our clinic for treatment of ocular adnexal tumors in both 
eyes.
Findings: Histologic examination showed that the neoplastic lesions consisted of atypical 
lymphoid cells, and the tentative diagnosis was malignant lymphoma. Immunophenotypic 
analyses by flow cytometry and immunohistochemistry showed that the atypical lymphoid cells 
expressed CD45, bcl-2, CD10, CD19, CD20, IgM, and kappa light chains. The cells were negative 
for CD5 and other T, natural killer, or myelomonocyte antigens. Southern blot hybridization 
demonstrated gene rearrangement bands in the immunoglobulin JH region. Fluorescence in situ 
hybridization studies showed a translocation at t(14,18)(q32,q21). Systemic evaluations detected 
enlargements of both the inguinal lymph nodes and parabronchial lymph nodes.
Conclusion: Our results show that flow cytometry, molecular genetic analyses, and chromosomal 
examination can be useful in differentiating follicular lymphoma from marginal zone B cell 
lymphoma of mucosa-associated lymphoid tissue and reactive lymphoid hyperplasia.
Keywords: fluorescence in situ hybridization, follicular lymphoma, Japanese, ocular adnexa, 
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Introduction
The classification of lymphomas has been controversial, and the Non-Hodgkin’s 
Lymphoma Pathologic Classification Project1 has classified lymphomas by morphologic 
characteristics, eg, cell size, cell shape, and growth pattern. This classification was 
developed before immunologic or genetic techniques were available, and it created 
heterogenous diagnostic categories. This then resulted in relatively low reproducibility 
in the diagnosis among pathologists. Since the early 1980s, it has become apparent that 
the use of more accurate characterizations of diseases would reduce the subjectivity 
of morphologic diagnosis and improve the rate of correct diagnosis. Thus, increasing 
the information about the biology of malignant lymphomas has led to significantly 
better diagnosis of diseases, and newer methods, such as immunohistochemistry and 
molecular biology, now being used routinely in pathology laboratories.
The classification of lymphoid tumors was improved in the Revised European-
American Lymphoma (REAL) classification,2 which was presented by the International 
Lymphoma Study Group in 1994. This classification was based on an update of the Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
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original Kiel classifications.3,4 This formed the basis of the 
new World Health Organization (WHO) classification of 
lymphomas in 2008,5 the latest classification of lymphoma, 
which is based upon the foundations laid within REAL.
The majority of lymphomas occurring in the ocular 
adnexa are B cell non-Hodgkin’s lymphomas. These are 
predominantly marginal zone B cell lymphomas of mucosa-
associated lymphoid tissues according to the new WHO 
classification. According to the WHO, lymphomas that occur 
in the ocular adnexa are the third most common B cell lym-
phomas occurring in Western Europe and North America.
Follicular lymphomas of the ocular adnexa are very rare in 
Japan and the other Asian countries.6 They are quite difficult 
to diagnose by their morphology alone because their low 
prevalence means that most physicians have not had first-hand 
experience of follicular lymphoma. With the introduction 
of newer examination techniques, such as flow cytometry, 
molecular genetic analyses, and chromosomal examinations, 
the differential diagnosis of follicular lymphomas has become 
easier and more accurate.
We report a 44-year-old woman who was diagnosed with 
follicular lymphoma involving the ocular adnexa by flow 
cytometry, molecular genetic analyses, and chromosomal 
examinations.
Case history
A 44-year-old woman visited the Tohoku University Hospital 
in March 2003 complaining of painless left upper eyelid 
swelling. She had no relevant medical history, although her 
father had stomach cancer. The initial ocular examination 
showed that her best-corrected visual acuity was 20/20 in 
each eye, and her eye movements were full in both eyes. 
Examination of the anterior and posterior segments of both 
eyes was normal. Magnetic resonance imaging scans of both 
orbits showed a well-defined 15 × 10 × 10 mm tumor in the 
region of the left lacrimal gland and a 3 × 5 × 3 mm tumor 
in the right lacrimal gland (Figure 1). A gallium scintigram 
showed high uptake spots corresponding to the ocular adnexal 
tumors and also in both inguinal lymph nodes.
At that point, we tentatively diagnosed her with malignant 
lymphoma. Laboratory examinations showed serum lactate 
dehydrogenase of 310 IU/L (normal = 119–229) and 465 U/mL 
of soluble interleukin-2 receptor (normal = 127–582).
In April 2003, a biopsy of the left ocular adnexal tumor 
was performed by an anterior percutaneous approach, and 
the tissue was forwarded to the registration-examination-
analysis-description (READ) system, which is a comprehen-
sive diagnostic laboratory for lymphoproliferative disorders 
(Koutou Biseibutsu Laboratories and Special Reference 
Laboratories, Tokyo, Japan). The results of their histologic 
examinations and other analyses of the biopsied tissues led 
to a diagnosis of follicular lymphoma.
The patient was referred to the Hematology Department 
for consultation, staging of the tumors, and further 
treatment. The staging investigations included full blood 
count, chest x-rays, computed tomography (CT) of the 
thorax, abdomen, head, and neck, and bone marrow biopsy. 
CT scans revealed enlargements of both the inguinal lymph 
nodes and parabronchial lymph nodes. Bone marrow biopsy 
was negative for lymphoma infiltration, and the patient 
was reported to be at Stage IIIA by the Ann Arbor clinical 
staging system.
The patient was treated with three cycles of chemotherapy 
consisting of cyclophosphamide, hydroxydaunorubicin 
(Adriamycin®), vincristine (Oncovin®), and CHOP (cyclo-
phosphamide, doxorubicin, vincristine, and prednisone) 
combined with rituximab. Rituximab is a synthetic antibody 
that was developed using cloning and recombinant DNA 
technology of human and mice genes. This therapy led to a 
regression of the tumors and the lymphadenopathy. At the 
T1 T2
Figure 1 Magnetic resonance imaging scans of both orbits showing a well defined 15 × 10 × 10 mm tumor in the region of the left lacrimal gland and a 3 × 5 × 3 mm tumor 
in the right lacrimal gland. signals higher than that of the external muscles in T1 image (right), and about the same intensity as brain cortex in the T2 image (left).Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1399
Follicular lymphoma of the ocular adnexa
time of the last medical examination in July 2010, the patient 
remained in complete remission.
Materials and methods
Histologic analysis
The biopsied tissues were fixed in 20% formalin and embed-
ded in paraffin. Sections were stained with hematoxylin and 
eosin, and immunochemical staining was performed with 
monoclonal antibodies to bcl-2, CD3, CD10, CD20, and 
CD21 (Dako Japan Co, Ltd, Kyoto, Japan).
Flow cytometry
Single-cell suspensions were prepared by cutting and teasing 
unfixed tissues in phosphate-buffered saline. The washed 
cells were incubated with the different monoclonal antibod-
ies and then injected into a Cytron Absolute flow cytometer 
(Ortho Diagnostic Systems, Raritan, NJ).
Cytogenetic analyses
Cells were cultured overnight in RPMI1640 with 15% fetal 
calf serum without mitogenic stimulation. The G-banded 
metaphases of the cells were determined by trypsin-treated 
Giemsa stain or hybridized with chromosomal specific fluo-
rescence probes and then karyotyped.
Fluorescence in situ hybridization
Double-labeled, two-color fluorescence in situ hybridiza-
tion (FISH) was performed on cells fixed in Carnoy’s 
fixative. The primers used were Vysis LSI IGH/BCL2 
Dual Color, Dual Fusion Translocation Probe (probe for 
14q32 region Immunoglobulin Heavy Chain Locus and 
18q21), and Vysis LSI API2/MALT1 t(11;18)(q21;q21) 
Dual Color, Dual Fusion Translocation Probe (probe for 
11q21 region and 18q21 region, Abbott Laboratories, 
Abbott Park, IL). The chromosomal probes were labeled 
by nick translation. After hybridization, the probes were 
detected by incubation for IgH gene and BCL2 gene. Nuclei 
were identified by 4-6-diamidino-2-phenylindole stain. 
The fluorescent signals were examined under a Nikon 
microscope (Nikon, Japan).
southern blot analyses
High molecular weight genomic DNA was extracted from the 
tissues. Ten micrograms of digested DNA was electrophore-
sed, blotted on a nylon membrane, and then hybridized with 
a 32P-labeled probe for the JH gene of the immunoglobulin 
heavy (µ) chain. After washing, the membrane was dried and 
exposed to x-ray film.
Results
Histologic examination of the biopsied tissues showed diffuse 
proliferation of atypical cells with occasional follicular pat-
tern (Figure 2). The cells resembled small lymphocytes and 
more like marginal zone cells than centrocytes. The follicular 
dendritic cell meshwork was relatively dispersed rather than 
condensed. Immunohistochemical analysis showed that 
the tumor cells expressed bcl-2, CD10, CD20, and CD21. 
CD10 stained only a small proportion of the cells in the nod-
ule. The presence of CD21-positive follicular dendritic cells 
was consistent with the follicle-like structure, and these cells 
were recognized as CD3-positive T cells (Figure 2).
Flow cytometry analyses showed that the atypical lymphoid 
cells expressed CD45, bcl-2, CD10, CD19, and CD20, IgM, 
and kappa, and were negative for CD5 and other T, natural 
killer, and myelomonocyte antigens (data not shown).
G-banded chromosome analyses were performed on 
12 cells in metaphase, and a clonal cytogenetic abnormality, 
a 48, XX,+X,add18(q21),+add(18)[11]/46,XX[1], was iden-
tified in 11 of 12 cells (Figure 3). Although the abnormality 
included the 18q21 locus, its partner allele locus of transloca-
tion was not clear for unknown reasons. However, the fusion 
FISH assay showed yellow signals which consisted of the 
fusion of green (IgH gene) and red (BCL2 gene) signals which 
suggested a t(14,18)(q32,q21) translocation. This was detected 
in 49/50 cells (Figure 4). No split signal was detected with split 
FISH assay for the MALT1 gene and cyclin D1 gene (data not 
shown). Southern blot analysis showed monoclonal rearranged 
bands in the immunoglobulin JH region (Figure 5).
B
C
D E F
b bcl cl- -2 2
CD10 CD10
CD CD2 20 0 CD CD2 21 1 CD3 CD3
A
Figure 2 Histologic and immunohistochemical analyses. A) Hematoxylin and eosin 
image.  There  is  a  diffuse  proliferation  of  atypical  cells  with  occasional  follicular 
pattern. B–F) Immunohistochemical images. The tumor cells expressed bcl-2 (B) and 
CD10 stains only a small proportion of the cells in the nodule (C), CD20 (D), and 
CD21 (E). A follicular pattern can be seen with CD3+ T cells (F). A) magnification × 2; 
B–F), magnification × 40.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Discussion
Differentiating mantle cell lymphoma, marginal zone lym-
phoma, and follicular lymphoma is difficult because the 
differentiating characteristics are based on morphologic 
features, such as cell size, cell shape, and growth pattern in 
tissues stained with hematoxylin and eosin. Thus, mantle 
cell lymphoma, marginal zone lymphoma, and follicular 
lymphoma were placed in the same group with the same 
morphologic features. With the development of new 
techniques, such as genetic, molecular, and immunological 
methods, the differentiation is easier and more accurate. The 
4th edition of the World Health Organization classification 
of tumors of hematopoietic and lymphoid tissues5 reported 
some new subtypes or variants of follicular lymphoma 
with distinct clinicopathologic and molecular genetic 
characteristics. Some of the early or precursor lesions of 
follicular lymphomas in situ are discussed.
The differentiation of follicular lymphoma from mantle 
cell lymphoma, marginal zone lymphoma, and reactive 
lymphoid hyperplasia is important because these lympho-
mas exhibit different clinical behaviors and outcomes. 
The results of G-banded cytogenetics of our case showed 
chromosomal abnormality in chromosome 18q21, but no 
translocation partner was identified in any chromosome 
including the IgH/14q32 locus. However, FISH analyses 
using probes for BCL2 and IgH provided direct evidence for 
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Figure 3 G-banded cytogenetic and spectral karyotyping. G-banded metaphase analysis revealed a 48,XX,+X,add18(q21),+add(18)[11]/46,XX[1] karyotype.
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Figure  4  Analysis  using  fluorescence  in  situ  hybridization  demonstrated  fusion 
yellow signals consisting of green (IgH gene) and red (BCL2 gene) signals, which 
directly suggested a t(14,18)(q32,q21) translocation, in 49/50 cells.
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Figure 5 southern blot analysis. Monoclonal rearranged bands were detected in the 
immunoglobulin JH region.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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their translocation. Our case was genetically characterized 
by a t(14,18)(q32,q21) translocation. This is particularly 
relevant because the IgH/BCL2 translocation has also been 
reported in extranodal mucosa-associated lymphoid tissue 
lymphomas in the stomach6–8 and skin.9 In addition, a MALT1 
gene abnormality and IgH/cyclin D1 gene fusion was not 
detected in the FISH analysis. Therefore, we diagnosed the 
tumors as a follicular lymphoma.
In diseases such as the chronic lymphoproliferative 
disorders which are characterized by a very low propor-
tion of mitotically active abnormal cells, traditional 
cytogenetic analysis is more likely to identify the karyo-
type of the normal dividing cells, and may miss the rare 
abnormal cell in mitosis. FISH can identify abnormalities 
missed by conventional cytogenetics and is helpful in the 
diagnosis, prognosis, and evaluation of therapy for chronic 
lymphoproliferative disorders such as chronic lymphocytic 
leukemia.10 FISH appears to be a more useful technique 
than other techniques and can provide the most reliable and 
accurate data. Immunohistochemical positivity for CD10 in 
the follicular lymphoma cells and their relationship with 
the BCL2 gene in FISH could be good evidence to diagnose 
our case as follicular lymphoma. On the other hand, a lack 
of an association with the cyclinD1 gene was evidence to 
exclude mantle cell lymphoma. In addition, no association 
with the MALT1 gene and the relationship with the BCL2 
gene in FISH would be evidence to exclude marginal zone 
lymphoma. Dierlamm et al showed that the API2 gene, and a 
novel gene on 18q21, characterized by several Ig-like C2-type 
domains named MLT, are recurrently rearranged in t(11;18). 
They suggested that the t(11;18)(q21;q21) appeared to be 
the key genetic lesion and is found in approximately 50% 
of cytogenetically abnormal low-grade mucosa-associated 
lymphoid tissue lymphomas.11
Thus, we diagnosed our case as follicular lymphoma from 
a combination of the results of all of these tests.
Follicular lymphomas are found less frequently in Asian 
countries than in Western countries (11%–33%),12 with lower 
rates having been found in Japan (6.7%–18%),13,14 Korea 
(5.88%),15 Hong Kong (8%),16 Taiwan (14%),17 and Thailand 
(3.8%–11.1%).18,19 The incidence of follicular lymphoma in 
Japan is less than 30% of the cases in Western countries. 
Notably, the incidence of follicular lymphoma in mainland 
Europe (11%–18%) is substantially less than that in North 
America and the UK. The reason for these differences is not 
known. Non-Hodgkin’s lymphomas in the ocular adnexal 
lymphomas are rare, and they are reported to account for 
only about 2% of all cases of non-Hodgkin’s lymphoma and 
about 5%–15% of all cases of non-Hodgkin’s lymphoma 
at extranodal sites.20–22 In addition, follicular lymphomas 
are known to occur in 23%–31%23–25 of ocular adnexal 
lymphomas. So the prevalence of follicular lymphoma in the 
ocular adnexa in the Japanese is very low. To the best of our 
knowledge, only two cases of follicular lymphoma derived 
from the conjunctiva have been reported.26,27 In our case, 
the tumor was bilateral and were localized in the lacrimal 
glands, and is thus not related to follicular lymphomas of 
the conjunctiva. However, in the analysis of the follicular 
lymphomas of the conjunctiva, polymerase chain reaction 
using the tumor DNA has detected a fusion product of the 
major breakpoint region of the BCL2 gene and IgH J region.27 
Because of the rareness and small sample of the ocular tumor, 
it was difficult to diagnose such a case as follicular lymphoma 
by conventional methods.
Recently, the efficacy of rituximab therapy for follicular 
lymphomas has been evaluated. A few clinical trials using 
rituximab alone for untreated follicular lymphomas28 and a 
few cases of conjunctival follicular lymphomas treated with 
rituximab alone have been reported.27 Generally, the common 
side effects of rituximab are not severe, and no side effect 
of rituximab was observed in our case.
In summary, our case with tumors in both eyelids was 
diagnosed as follicular lymphoma with a combination of 
the findings of immunohistochemical and molecular genetic 
techniques. We conclude that the insights into the pathogen-
esis of lymphoid malignancies through new techniques such 
as genetic, molecular, and immunologic methods would help 
as complementary methods for the diagnosis, and lead to 
more accurate diagnosis and proper treatment.
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